Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Fevertree (FEVR) Share Price

Price 794.50p on 07-07-2026 at 08:38:41
Change 13.50p 1.73%
Buy 796.00p
Sell 792.00p
Last Trade: Unknown 0.00 at 796.00p
Day's Volume: 43,308
Last Close: 781.00p
Open: 819.00p
ISIN: GB00BRJ9BJ26
Day's Range 786.00p - 819.00p
52wk Range: 711.00p - 1,020.00p
Market Capitalisation: £898.67m
VWAP: 785.71328p
Shares in Issue: 113.11m

Fevertree (FEVR) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 0 796.00p SI Trade
09:38:41 - 07-Jul-26
Buy* 5 796.00p SI Trade
09:37:35 - 07-Jul-26
Buy* 14 796.00p SI Trade
09:37:35 - 07-Jul-26
Buy* 179 794.50p Automatic Execution
09:37:35 - 07-Jul-26
Buy* 64 794.50p Automatic Execution
09:37:35 - 07-Jul-26
Buy* 132 794.50p Automatic Execution
09:37:35 - 07-Jul-26
Buy* 83 794.50p Automatic Execution
09:37:35 - 07-Jul-26
Sell* 103 793.50p Automatic Execution
09:37:35 - 07-Jul-26
Sell* 100 793.50p Automatic Execution
09:37:35 - 07-Jul-26
Buy* 97 795.50p Automatic Execution
09:37:35 - 07-Jul-26
See more Fevertree trades

Fevertree (FEVR) Share Price History

Time period:
to
Date Open High Low Close Volume
6th Jul 2026 (Mon) 804.50 804.50 781.00 781.00 239,984
3rd Jul 2026 (Fri) 814.00 814.00 799.00 800.00 167,152
2nd Jul 2026 (Thu) 819.50 822.00 806.00 806.00 343,484
1st Jul 2026 (Wed) 815.50 821.50 799.50 817.50 291,983
30th Jun 2026 (Tue) 780.00 817.00 780.00 812.50 823,128
29th Jun 2026 (Mon) 780.00 823.00 780.00 810.00 1,484,296
26th Jun 2026 (Fri) 800.00 821.50 785.00 816.50 698,143
25th Jun 2026 (Thu) 832.00 832.00 809.50 825.50 427,691
24th Jun 2026 (Wed) 800.00 826.50 797.50 821.50 983,385
23rd Jun 2026 (Tue) 804.00 804.00 786.00 796.50 380,500
22nd Jun 2026 (Mon) 823.00 823.00 790.00 802.50 316,454
19th Jun 2026 (Fri) 799.00 846.50 799.00 807.00 281,886
18th Jun 2026 (Thu) 864.50 864.50 812.50 829.00 385,432
17th Jun 2026 (Wed) 869.00 869.00 840.00 847.00 370,193
16th Jun 2026 (Tue) 835.50 843.50 822.50 840.00 339,659
15th Jun 2026 (Mon) 840.00 864.00 830.50 835.50 329,221
12th Jun 2026 (Fri) 839.50 864.00 837.50 840.00 337,517
11th Jun 2026 (Thu) 815.00 837.50 815.00 830.50 480,731
10th Jun 2026 (Wed) 800.00 827.00 795.00 827.00 319,469
9th Jun 2026 (Tue) 821.00 821.50 790.50 797.50 627,867
8th Jun 2026 (Mon) 780.50 780.50 745.00 759.00 455,556
See more Fevertree price history

Fevertree (FEVR) Regulatory News

Date Source Headline
1st Jul 2026 10:20 am RNS Total Voting Rights
1st Jul 2026 7:00 am RNS Update on share buyback extension
30th Jun 2026 9:42 am RNS Board Change
30th Jun 2026 7:00 am RNS Transaction in Own Shares
23rd Jun 2026 7:00 am RNS Transaction in Own Shares
16th Jun 2026 7:00 am RNS Transaction in Own Shares
9th Jun 2026 12:46 pm RNS Results of AGM
9th Jun 2026 7:00 am RNS AGM Trading Statement
9th Jun 2026 7:00 am RNS Transaction in Own Shares
2nd Jun 2026 7:00 am RNS Transaction in Own Shares
See more Fevertree regulatory news

Fevertree (FEVR) Share News

IN BRIEF: Fevertree Drinks starts GBP30 million buyback extension

1st Jul 2026 13:52

Fevertree Drinks PLC - London-based maker of premium drink mixers - Fevertree starts the GBP30 million extension of its share buyback programme, which it had announced at its annual general meeting last month. The new GBP30 million buyback follows a buyback of the same size completed earlier in the year. It begins on Wednesday and will be completed by December 31. It will be run by Investec Bank PLC. Read More

UK dividends calendar - next 7 days

19th Jun 2026 12:11

Read More

Fevertree Drinks extends share buyback after solid start to year

9th Jun 2026 11:26

(Alliance News) - Fevertree Drinks PLC on Tuesday announced a GBP30 million extension to its share buyback programme and said it remains confident of achieving full-year market expectations. Read More

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent

9th Jun 2026 07:58

(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Bellway reports an "increasingly challenging" housing market. Read More

UK shareholder meetings calendar - next 7 days

2nd Jun 2026 13:44

Read More

See more Fevertree news
FTSE 100 Latest
Value10,698.29
Change46.52

Login to your account

Forgot Password?

Not Registered